An experimental gene therapy slowed Huntington’s by up to 75 percent in a small clinical trial. While not a cure, it may give patients longer lives.

Huntington’s disease (HD) is a condition that is hereditary and causes nerve cells in specific parts of the brain to slowly deteriorate and die. The disorder affects regions responsible for controlled ...

UniQure said the U.S. Food and Drug Administration no longer agreed that clinical data for the Dutch company's gene therapy ...

Researchers and families unite to address Huntington's disease, exploring innovative therapies and fostering connections at ...

At an awareness seminar on World Alzheimer's Day in Bangalore, India, in 2024, a participant walks past. On Wednesday, University College London medical researchers announced what they say is the ...

Researchers announce breakthrough results for AMT-130, the first disease-modifying treatment for Huntington's disease, with ...

Jagadeesha's brain, the first juvenile Huntington's Disease donation in India, offers hope for vital neurodegenerative research at NIMHANS.

Sex influences how genetic and age-related factors translate into clinical and neuroimaging trajectories in Huntington disease.

An exceptionally rare and fatal genetic disease may finally have a solution. Huntington’s Disease affects one in ten to twenty thousand Americans. The disease is a mixture of dementia and Parkinson’s, ...

The United States Huntington's Disease Treatment Market is set to expand significantly, with an expected CAGR of 15.22% from ...

Nora Guthrie is in Scotland to highlight the work of the Scottish Huntington’s Association. The daughter of American folk ...